Eastwood

Bio-Medical

Canada Inc.

(EBM) July 4, 2018

2018年7月4日

1130-4871 Shell Road, Richmond, BC, Canada V6X 3Z6 1

This presentation contains forward-looking statements and forward-looking information within the meaning of applicable

securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may",

"will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking

information or statements. The forward-looking statements and information are based on certain key expectations and

assumptions made by the Eastwood Bio-Medical Canada Inc. (the Company) and the Company’s affiliates, including

expectations and assumptions concerning TSX Venture Exchange approvals. Although the Company believes that the

expectations and assumptions on which such forward-looking statements and information are based are reasonable,

undue reliance should not be placed on the forward-looking statements and information because the Company can give no

assurance that they will prove to be correct.

Forward-Looking Statement / 前瞻性陳述

2

Eastwood Bio-Medical Canada Inc. is located at Richmond, British

Columbia, Canada near the Vancouver International Airport.

Eastwood Bio-Medical Canada Inc.位於加拿大卑詩省列治文，臨近溫

哥華國際機場。

3

Canadian History in Diabetes Leadership

加拿大是糖尿病行業的全球先驅

Canada has long been considered the global

pioneer of diabetes industry. In 1922, Frederick

Grant Banting discovered insulin, which is

considered one of the most important

discoveries of the 20th century. The Nobel

Foundation awarded his team Nobel Prize in

Physiology and Medicine in 1923.

人們長期以來一直將加拿大視為糖尿病行 業的全球先驅。1922年，弗雷德裡克·班廷 (Frederick Grant Banting)發現了胰島素，這 被認為是20世紀最重要的發現之一。諾貝 爾基金會於1923年授予弗雷德裡克·班廷的 團隊諾貝爾生理學和醫學獎。

4

Who We Are

關於我們

5

A biomedical research and development company specializing in metabolic

disorders such as diabetes, obesity, hypertension, and Alzheimer‘s disease.

一家生物醫學研發公司，致力於研究糖尿病、肥胖症、高血壓和阿爾 茨海默病等代謝紊亂疾病的解決方案。

We have successfully developed over 70 Eleotin® products including over 50

Health Canada (Canadian FDA) approved products.

我們已經成功開發了70多種Eleotin®產品，其中包括50多種加拿大衛生 部（加拿大FDA）批准的產品。

Advertising Standards Canada (ASC) approved our flagship product, Eleotin®

Bentley to be marketed as ―World‘s #1 Doctor recommended Natural Source

Healthy Blood Glucose Promoting Product available in Canada‖.

加拿大廣告標準委員會(ASC)批准本公司的旗艦產品Eleotin® Bentley用 ―世界第一醫生推薦的純天然加拿大健康血糖促進產品‖名義

進行市場推廣。

ASC

Approval

Number

ASC批准 文號

6

Who We Are

關於我們

7

Over 500,000 users are estimated to have used and benefited from

Eleotin® .

估計有超過500,000名使用者用過Eleotin®並從中受益。

More than four international diabetes associations strongly recommend

(endorsed) Eleotin® .

超過四個國際糖尿病協會強烈推薦（認可）Eleotin®。

Eleotin® was the recipient of 2010 Best Metabolism Disorder

Treatment of the Year Award and

Eleotin®獲得2010年度最佳新陳代謝紊亂治療獎和

7th Annual International Brand Packing Awards

第七屆年度國際品牌包裝獎

EBM: The Recent Focus of Financial Analysts and

Investors EBM：金融分析師和投資者近期所關注的焦點

Company production capacity ‗recently‘ has

increased to:

公司產能―最近‖實現增長：

▰ Up to 3 million capsules can be

produced and 10,000 bottles can be

packaged per day.

每天可生產多達300萬粒膠囊，每 天可包裝10,000瓶膠囊。

▰ A half million dollar worth of products

in retail value can be produced daily.

每天可生產零售價值達$50萬的產 品。

▰ Up to $7 million in possible savings in annual manufacturing costs.

所節約的年度製造成本高達$700萬。 8

EBM: The Recent Focus of Financial Analysts and

Investors EBM：金融分析師和投資者近期所關注的焦點

9

EBM: The Recent Focus of Financial Analysts and

Investors EBM：金融分析師和投資者近期所關注的焦點

New Product Approvals and Licenses (45 NPN Numbers).

新產品批號和許可證（45 NPN批號）。

10

June 29 2018, Eastwood Bio-Medical Canada Enters Binding Terms for Asian

Exports

2018年6月29日，Eastwood Bio-medical Canada Inc.簽訂產品出口亞洲協議

11

▰ On June 29 2018, EBMC announced to enter binding terms for

Asian exports. Accordingly, 900% increase in revenue was

announced.

2018年6月29日，EBMC宣佈與一家亞洲分銷公司就採購訂單 達成具有約束力的條款。因此，EBMC宣佈收入增加900%。

▰ New manufacturing capabilities allow us to finally start producing

highly advanced and complex products with the best quality and

process control on a meaningfully larger scale.

新的製造能力令我們能夠大幅提高產能，採用最佳的工藝控 制技術，開始生產非常先進、複雜的高品質產品。

▰ EBMC is no longer being bound by production limitations.

EBMC不再受產量限制的約束。

Stock Prices in the Past 6 Months

過去6個月股價

The market has begun paying attention.

市場開始關注本公司。

12

Trading Volume in the Past 6 Months

過去六個月成交量

15 Jan 29 Jan 12 Feb 26 Feb 12 Mar 26 Mar 9 Apr 23 Apr 7 May 21 May 4 Jun 18 Jun 2 Jul

601 K

13

Market Potential: Prevalence of Diabetes By IDF Region

市場潛力：國際糖尿病聯盟地區的糖尿病患病率

14 Global Report on Diabetes – WHO 2016

全球糖尿病報告——世衛組織2016年

Market Potential: Prevalence of Alzheimer‘s and Dementia

市場潛力：阿爾茨海默氏症和癡呆症的患病率

15

全球的阿爾茨海默氏症和癡呆症患者

Market Potential: Prevalence of Hypertension

市場潛力：高血壓病的患病率

16

Global Prevalence of Hypertension

over 1.3 Billion

全球有超過13億高血壓病患者

Market Values of Diabetes, Hypertension and Alzheimer‘s

糖尿病、高血壓和阿爾茨海默氏症的市場規模

17

▰ Type 2 diabetes market to more than double, to $64 billion by 2026

治療2型糖尿病的市場規模將增加一倍以上，到2026年達到 $640億

▰ Global hypertension market will reach USD $32 billion by the end of

2020

到2020年底，全球治療高血壓病的市場規模將達到320億美元。

▰ The global Alzheimer's market is expected to $10.4 billion in 2021

預計到2021年，全球治療阿爾茨海默氏症的市場規模將達 $104億

Our Claim: The Only Option

我們的主張：我們的產品是患者的唯一選擇

18

We believe that our products are the ‗only‘ option for

those inflicted with these diseases.

我們相信，我們的產品是患有這些疾病的患者的 “唯一”選擇。

We also believe we will remain the only option in the

near future.

我們也相信，在不久的將來，我們的產品仍將是 患者的唯一選擇。

Here is why...

理由是…

Pharmaceuti

cal Drugs and

Insulin

Other Herbal

Products

Traditional

Chinese Medicine

Folkloric

Treatmen

ts/

Alternative

Treatments

Eleotin®

Known - Can be

used with other

pharmaceutical

drugs

Unknown

Unknown

Unknown

Known - Can be

safely used with

other

pharmaceutical

drugs

19

Advantage #1: Modes of Action Known

● The Modes of Actions for most non-pharmaceutical treatments are unproven. They can

not be used with pharmaceutical drugs out of fear of unknown adverse interactions.

● Eleotin® 's modes of actions are known and proven. Eleotin® is safe when used with

oral pharmaceutical drugs and insulin.

● In fact, Eleotin® reduces the side effects and resistance of oral pharmaceutical drugs

and insulin. When used with Eleotin®, oral pharmaceutical drugs and insulin become

safer more efficacious and less habit forming.

藥物和胰島素

其他草藥

中藥

民間療法/非傳統療法

Eleotin®

已知——可與其 他藥物一起

使 用

未知

未知

未知

已知——可安全 地與其他藥物 一起使用

20

優勢1：作用機制已知

● 大多數非藥物療法的作用機制尚未得到證實。 由於擔心未知的不良相互作 用，非藥物療法不能與藥物一起使用。

● Eleotin®的作用機制眾所周知。 當Eleotin®與口服藥物和胰島素一起使用時， Eleotin®安全有效。

● 事實上，Eleotin®能減少口服藥物和胰島素的副作用和抗藥性。當口服藥物 和胰島素與Eleotin®一起使用時，能實現安全有效的療效並減少藥物依賴。

21

Pharmaceuti

cal Drugs and

Insulin

藥物和胰島素

Other Herbal

Products

其他草藥

Traditio

nal

Chinese

Medicine

中藥

Folkloric Treatments/

Alternative

Treatments

民間療法/非傳統療法

Eleotin®

None

無

None

無

Unknown

未知

None

無

Semi-

permanent efficacy

半永久性的長期改善

Advantage #2: Long Term Effects

優勢2：長期影響

● With proven insulin resistance reduction, Eleotin® provides semi-permanent long

term improvement while other treatments do not give such long term benefits.

隨著胰島素抗病力的降低，Eleotin®可提供半永久性的長期疾病改善，而其他治療方法則 無法帶來長期效益。

● Most other treatments only have short term control benefits, and must be used permanently.

大多數其他療法只有在短期內控制疾病，必須永久使用這些療法。

● But a person can stop Eleotin® with no harmful side effects after the body has a attained structural

change. 但使用Eleotin®的患者在身體實現結構變化後，可以停止使用Eleotin®並且沒有任

何有害副作用。

Pharmaceuti

cal Drugs and

Insulin

藥物和胰島素

Other Herbal

Products

其他草藥

Traditional

Chinese Medicine

中藥

Folkloric

Treatmen

ts/

Alternative

Treatments

民間療法/非傳

統療法

Eleotin®

No

否

No

否

No

否

No

否

Yes

是

22

Advantage #3: Preventive Effects

優勢3：預防效果

● A person who does not have diabetes can use Eleotin® for general health and

preventive purposes. Other treatments do not offer such safe options.

非糖尿病患者可以用Eleotin®改善健康狀況和進行糖尿病預防。其他療法無 法提供這一安全選項。

Pharmaceutical

Drugs and Insulin

藥物和胰島素

Other Herbal

Products

其他草藥

Traditional

Chinese Medicine

中藥

Folkloric Treatments/

Alternative

Treatments

民間療法/非傳統療法

Eleotin®

Short term and

invasive treatment.

Toxic and severe

side effects.

Resistance

develops. Ever

increasing dosages.

短期和侵入性治療、 有毒和嚴重的副作 用、產生抗藥性、 需要不斷提高劑量。

Shotgun

approach. Most of

them rely on

artificial

indigestion to

lower the blood

sugar

突擊式營銷。大 多依靠人為製造 消化不良來降低

血糖

Shotgun approach.

Most of them rely

on artificial

indigestion to

lower the blood

sugar

突擊式營銷。大 多依靠人為製造 消化不良來降低

血糖

Shotgun approach.

Most of them rely on

artificial indigestion

to lower the blood

sugar

突擊式營銷。大多 依靠人為製造消化 不良來降低血糖

Long term and

safe beneficial

effects. General

health

improvements.

長期安全的療效， 改善總體健康狀

況

23

Conclusion 結論

● If you compare Eleotin® with other treatments from all perspectives, it‘s natural to

conclude that Eleotin® is the only option.

如果您從所有角度比較Eleotin®與其他療法，就能自然地得出結論：Eleotin®

是唯一的選擇。

ASC approved Eleotin® to be ―World‘s #1 Doctor recommended Natural Source Healthy Blood Glucose

Promoting Product available in Canada‖.

加拿大廣告標準委員會(ASC)批准Eleotin用―加拿大市場上全球首個醫生推薦的天然來源健康血糖 促進產品‖名義進行市場推廣。

● World‘s No.1 Doctor recommended: Over 3000+ doctors / 全球首個醫生推薦：逾3000名醫生推薦

● Over 2,500 Newspaper & Television Acclaims (including New York Times #1 Best Sellers) / 得到超過

2500條報紙和電視臺讚譽（包括《紐約時報》排名第一的暢銷書 ）

● Researched/Clinically tested by Universities and Governments / 由大學和政府進行研究/臨床測試

● Strongly recommended by more than 4 International Diabetes Associations / 得到4個以上國際糖尿

病協會的強烈推薦

● Licenses issued by 8 Government Authorities / 獲得8個政府機關簽發的許可證

● Best Metabolism Disorder Treatment of the Year 2010 Award Winner / 獲得2010年度最佳新陳代謝

紊亂治療獎

● More than 500,000 Users as of beginning of this year / 截至今年年初，已有超過500,000名使用者

● Over 2,000 Youtube testimonials / 超過2,000個Youtube視頻推薦

24

As a Result,

因此，

International Diabetes Associations Endorsements of

Eleotin®

國際糖尿病協會認可Eleotin®

25

26

Recommendations of Medical

Professionals

Dr. Chu, Beijing China “Because of Eleotin my

husband doesn’t need any

pharmaceutical drugs. He’s normal now.”

Dr. J. Yoon “This remedy will restore

near normalcy for 70% of

Type II diabetics.”

Dr. M. Kuypers “I am using it myself, with

great benefit. My own

experience have been

most encouraging. I am

looking forward to finally

being able to do

something about insulin

resistance.”

Dr. L. Lipskaya, Bacteriologist

“After I started using Eleotin, I

felt an improvement in my

health conditions. Now I

recommend Eleotin to every

person who are suffering from

Type II diabetes.”

Dr. E. Echano “Everyone should know about

this. i observed excellent

clinical result. This unique

herbal formulations long

lasting effects are truly

amazing.”

Dr. M. Sichel “A pathfinding discovery

in the reversal of

diabetes.”

Dr. D. Walker “Eleotin is effective in

regulating blood glucose

levels.”

Dr. C. L. Broadhurst “Eleotin is blend of many

promising herbs that

dramatically lower blood

sugar.”

Dr. P. Singh Ayurvedic Medicine

“I want to recommend

Eleotin especially to Type II

diabetics. It will help them in

controlling their blood

glucose levels.”

Recommendations of Medical Professionals

醫療專業人員推薦

Chu博士，中國北京 “因為Eleotin，我的丈夫不需

要任何藥物。他現在過著正 常健康的生活。”

J. Yoon博士 “對於70%的2

型糖尿病患者， 這種藥物將使患者恢復到接 近健康正常的狀態。”

M. Kuypers博士 “我自己使用它，它給我帶來

了很大的好處。我自己的經 歷是最令人鼓舞的。我期待 著能夠對胰島素抗藥性做些 什麼。”

L. Lipskaya博士，細菌學家 “在我開始使用Eleotin之後，我感 覺自己的健康狀況有所改善。現在 我向所有患有II型糖尿病的人推

薦 Eleotin。”

E. Echano 博士 “每個人都應該知道這一點。我 觀察到Eleotin有極好的臨床效果。

這種獨特的草藥配方有持久療效， 確實令人驚歎。”

M. Sichel博士 “Eleotin是逆轉糖尿病的突破 性發現。”

D. Walker博士 “Eleotin可有效調節血糖水 平。”

C. L. Broadhurst博士 “Eleotin由許多草藥混合而成， 可以顯著降低血糖。”

P. Singh博士 阿育吠陀醫學 “我想特別向II型糖尿病患者推 薦Eleotin。它將幫助患者控制 血糖水平。”

27

Clinical Studies, Publications, Approvals and Licenses

臨床研究、出版物、批文和許可證

28

Clinical Studies, Publications, Approvals and Licenses

臨床研究、出版物、批文和許可證

29

Clinical Studies, Publications, Approvals and Licenses

臨床研究、出版物、批文和許可證

Comments on Eleotin by

Korean National Diabetes

Association

韓國國家糖尿病協會對 Eleotin的評論

30

Clinical Studies, Publications, Approvals and Licenses

臨床研究、出版物、批文和許可證

Comments on Eleotin by

Korean Pharmaceutical

Manufacturers‘ Association

韓國藥品製造商協會對 Eleotin的評論

31

Africa's Best Diabetic & Hypertension Management Drug in 2010

2010年非洲最佳糖尿病和高血壓管理藥物

32

Testimonials

推薦材料

33

We have over 5,000 video testimonials on Youtube by users and doctors

with all real names and many contact information to verify.

我們在Youtube上有超過5,000個使用者和醫生的推薦視頻，使用者

和醫生提供真實姓名和許多聯繫信息，以驗證真實性。

Established Retail Lines

成熟的產品線

Eleotin® Bentley

● Helps promote healthy glucose levels.

有助於促進達到健康血糖水平。 ● Long-term blood glucose normalization effects.

達到長期實現正常血糖的效果。 ● General health improvement.

提升總體健康狀況。

Eleotin® Ma5

● Powerful anti-oxidation powers that are

preserved superbly.

強大的抗氧化能力，保存完好。 ● High quality Vitamin C group ingredients.

含高品質的維生素C組成份。

34

Established Retail Lines

成熟的產品線

Eleotin® LBM

● for hyperactivity of the liver (high blood pressure). 用於肝過度活躍（高血壓）。

● To cut the vicious cycle between high blood sugar and

high blood pressure caused by prescription drugs.

減少處方藥引起的高血糖和高血壓之間的惡性循環。

Eleotin® Pedo-Protection Socks Eleotin® 保護襪 ● Anti-Fungal & Anti-Bacterial

抗真菌和抗菌 ● Auto Regulating Mesh Top

自動調節頂部網狀設計 ● Treated Inner Toe Seam

腳趾縫舒適 ● Holistic & Gentle Neck Pressure

舒緩腳脖壓力 35

Founder - Dr. Youngsoo Kim

創始人 – 金榮洙博士

● Advises Various Governments and senior management of numerous

Korean firms including Hyundai, Gold Star, and Samsung

為各個政府、包括現代、金星和三星在內的眾多韓國企業的

高級管理人員提供建議

● CEO of Mutsumi Enterprises Canada Corp.

Mutsumi Enterprises Canada Corp.首席執行官

● Vice President of Toshin Butsuryu (Toyota Automobile Group

Japan)

東新物流株式會社（豐田（日本）汽車集團）副總裁

● Protocol secretary in the Korean Presidential Palace

韓國總統府禮賓司秘書

● Assistant Professor of Finance at the University of Alberta in

Edmonton

埃德蒙頓阿爾伯塔大學金融學助理教授

● Massachusetts Institute of Technology (Ph.D. in Economics) 1987

1987年畢業于麻省理工學院（經濟學博士）

36

Board of Directors

董事會成員

Yunji Kim President, CEO and Director 總裁、首席執行官兼董事

● President since April 2013, Director since October 2012 2013年4月起擔任總裁； 2012年10月起擔任董事

● New York State Bar admission 2012 2012年加入紐約州律師協會

● LL.M. in Taxation, Georgetown University Law Center, 2011 2011年獲得了喬治敦大學法 學院法學碩士學位

37

Peter Chen CFO and Director 首席財務官兼董事

● Executive Director of Proterra Management Group Inc. 目前在私營諮詢公司Proterra Management Group Inc.擔任 執行董事。

Dr. Marcus Kuypers Marcus Kuypers博士 Director 董事

● Medical Doctor 醫學博士

● Physician at AB Staffing since November 2011 自2011年11月至今一直是AB Staffing的在職醫生

● Accretive Health from October 2011 to February 2013 2011年10月至2013年2月任職 於Accretive Health

● Doctors Home Visits from September 2001 to August 2011 2001年9月至2011年8月在 Doctors Home Visits供職

● Emergency Medicine physician since November 2011 自2011年11月至今，一直擔 任急救醫生。

Dr. Terrance Owen Terrance Owen博士 Director 董事

● Director of Pacific Paredyme Energy Inc. 目前擔任Pacific Paradyme Energy Inc.董事

● CEO of CellMedX Corp. 擔任CellMedx Corp.首席執行官

● President and CEO of Nuva Pharmaceuticals Inc. until June 2013 2013年6月前曾擔任Nuva Pharmaceuticals Inc.的總裁兼 首席執行官。

Appendix - Financial Information

附錄——財務信息

38

Most updated information available upon request

請在網站上申請獲取公司最新信息

www.eleotin.ca

www.eleotin.cn

Yunji Kim

Unit 1130-4871 Shell Road Richmond, B.C. Canada, V6X 3Z6

604.247.2100 or 1.888.669.4372

yunjikim@eastwoodcos.com

www.eleotin.ca

www.eleotin.cn 39